Search Results for: PRKCD

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
Novel NSD1 nuclear receptor binding SET domain protein 1
  • PKMTs methylate histone lysines
  • Beckwith-Wiedemann syndrome
  • Sotos syndrome and Weaver syndrome
ACTA1 actin alpha 1, skeletal muscle
  • Striated Muscle Contraction
  • Latrunculin A
  • Sucrose
  • Ulapualide A
  • Kabiramide C
  • Jaspisamide A
  • Tmr
  • 1-Methylhistidine
  • Phosphoaminophosphonic Acid-Adenylate Ester
  • Aplyronine A
  • Reidispongiolide A
  • Reidispongiolide C
  • Sphinxolide B
  • Latrunculin B
  • Congenital fiber type disproportion (CFTD)
  • Cap myopathy
  • Nemaline myopathy
ACTA2 actin alpha 2, smooth muscle
  • Smooth Muscle Contraction
  • NOTCH4 Intracellular Domain Regulates Transcription
  • Phenethyl Isothiocyanate
  • Familial thoracic aortic aneurysm and dissection (TAAD); Aortic aneurysm familial thoracic type (AAT)
ACTB actin beta
  • Translocation of SLC2A4 (GLUT4) to the plasma membrane
  • Gap junction degradation
  • Formation of annular gap junctions
  • Regulation of actin dynamics for phagocytic cup formation
  • Regulation of actin dynamics for phagocytic cup formation
  • HATs acetylate histones
  • Prefoldin mediated transfer of substrate to CCT/TriC
  • Folding of actin by CCT/TriC
  • EPHB-mediated forward signaling
  • EPH-ephrin mediated repulsion of cells
  • Adherens junctions interactions
  • Adherens junctions interactions
  • Recycling pathway of L1
  • Recycling pathway of L1
  • VEGFA-VEGFR2 Pathway
  • Interaction between L1 and Ankyrins
  • Interaction between L1 and Ankyrins
  • Cell-extracellular matrix interactions
  • B-WICH complex positively regulates rRNA expression
  • RHO GTPases activate IQGAPs
  • RHO GTPases Activate WASPs and WAVEs
  • RHO GTPases Activate WASPs and WAVEs
  • RHO GTPases Activate Formins
  • RHO GTPases Activate Formins
  • MAP2K and MAPK activation
  • UCH proteinases
  • DNA Damage Recognition in GG-NER
  • Signaling by moderate kinase activity BRAF mutants
  • Signaling by high-kinase activity BRAF mutants
  • Signaling by BRAF and RAF fusions
  • Paradoxical activation of RAF signaling by kinase inactive BRAF
  • Clathrin-mediated endocytosis
  • Signaling downstream of RAS mutants
  • Signaling by RAF1 mutants
  • FCGR3A-mediated phagocytosis
  • FCGR3A-mediated phagocytosis
  • Factors involved in megakaryocyte development and platelet production
  • Quercetin
  • Phenethyl Isothiocyanate
  • Other phagocyte defects, including the following eight diseases: Chediak-Higashi syndrome; Griscelli syndrome, type 1 (GS1); Griscelli syndrome, type 2 (GS2); Griscelli syndrome, type 3 (GS3); beta-actin deficiency; Neutrophil-specific granule deficiency; Myeloperoxidase deficiency; Glucose 6-phosphate dehydrogenase deficiency; Shwachman syndrome
ADAM9 ADAM metallopeptidase domain 9
  • Collagen degradation
  • INCB7839
  • Cone-rod dystrophy and cone dystrophy, including: Cone-rod dystrophy (CORD); Cone dystrophy (COD); Retinal cone dystrophy (RCD)
ADCY7 adenylate cyclase 7
  • Glucagon signaling in metabolic regulation
  • PKA activation
  • PKA activation in glucagon signalling
  • Adenylate cyclase activating pathway
  • Adenylate cyclase inhibitory pathway
  • Adenylate cyclase inhibitory pathway
  • G alpha (s) signalling events
  • G alpha (s) signalling events
  • G alpha (i) signalling events
  • G alpha (z) signalling events
  • G alpha (z) signalling events
  • Vasopressin regulates renal water homeostasis via Aquaporins
  • Hedgehog 'off' state
  • ADORA2B mediated anti-inflammatory cytokines production
  • ADORA2B mediated anti-inflammatory cytokines production
  • FCGR3A-mediated IL10 synthesis
ADD1 adducin 1
  • Caspase-mediated cleavage of cytoskeletal proteins
  • XBP1(S) activates chaperone genes
  • Miscellaneous transport and binding events
ADD2 adducin 2
  • Miscellaneous transport and binding events
ADRA2A adrenoceptor alpha 2A
  • Adrenoceptors
  • Adrenaline signalling through Alpha-2 adrenergic receptor
  • Adrenaline,noradrenaline inhibits insulin secretion
  • G alpha (i) signalling events
  • G alpha (z) signalling events
  • Surfactant metabolism
  • Amphetamine
  • Tramadol
  • Bethanidine
  • Ziprasidone
  • Cabergoline
  • Ropinirole
  • Dihydroergotamine
  • Amitriptyline
  • Clozapine
  • Norepinephrine
  • Mirtazapine
  • Phenylpropanolamine
  • Loxapine
  • Pramipexole
  • Prochlorperazine
  • Dipivefrin
  • Prazosin
  • Chlorpromazine
  • Brimonidine
  • Haloperidol
  • Nortriptyline
  • Amoxapine
  • Amoxapine
  • Lamotrigine
  • Clonidine
  • Lisuride
  • Guanabenz
  • Dexmedetomidine
  • Trazodone
  • Epinephrine
  • Phentolamine
  • Ergotamine
  • Tizanidine
  • Apomorphine
  • Paroxetine
  • Trimipramine
  • Epinastine
  • Tolazoline
  • Fenoldopam
  • Pseudoephedrine
  • Benzphetamine
  • Phenoxybenzamine
  • Maprotiline
  • Oxymetazoline
  • Apraclonidine
  • Methyldopa
  • Guanfacine
  • Ergoloid mesylate
  • Promethazine
  • Carvedilol
  • Nefazodone
  • Desipramine
  • Escitalopram
  • Pergolide
  • Bromocriptine
  • Quetiapine
  • Aripiprazole
  • Paliperidone
  • Ephedra sinica root
  • Mephentermine
  • Yohimbine
  • Methotrimeprazine
  • 4-Methoxyamphetamine
  • Dextroamphetamine
  • Metamfetamine
  • Periciazine
  • Zuclopenthixol
  • Celiprolol
  • Dronedarone
  • Lofexidine
  • Epicept NP-1
  • Mianserin
  • Pizotifen
  • Asenapine
  • Ocaperidone
  • Droxidopa
  • Flupirtine
  • Esmirtazapine
  • Xylometazoline
  • Levonordefrin
  • Naphazoline
  • Lurasidone
  • Dosulepin
  • Etoperidone
  • Lorpiprazole
  • Cirazoline
  • Moxisylyte
  • Aranidipine
  • Moxonidine
  • Pirlindole
  • Pipamperone
  • Setiptiline
  • Racepinephrine
  • Dihydroergocornine
  • DL-Methylephedrine
  • DL-Methylephedrine
  • Xylazine
  • Indigotindisulfonic acid
  • Rilmenidine
  • Tiapride
  • Dihydroergocristine
  • Aripiprazole lauroxil
ADRB2 adrenoceptor beta 2
  • Adrenoceptors
  • G alpha (s) signalling events
  • Ub-specific processing proteases
  • Cargo recognition for clathrin-mediated endocytosis
  • Clathrin-mediated endocytosis
  • ADORA2B mediated anti-inflammatory cytokines production
  • Spermine
  • Amphetamine
  • Betaxolol
  • Bethanidine
  • Isoetharine
  • Cabergoline
  • Metoprolol
  • Olanzapine
  • Atenolol
  • Norepinephrine
  • Timolol
  • Phenylpropanolamine
  • Dipivefrin
  • Sotalol
  • Carteolol
  • Nortriptyline
  • Propranolol
  • Labetalol
  • Bisoprolol
  • Epinephrine
  • Paroxetine
  • Trimipramine
  • Cryptenamine
  • Orciprenaline
  • Dobutamine
  • Pseudoephedrine
  • Alprenolol
  • Ritodrine
  • Terbutaline
  • Bitolterol
  • Phenoxybenzamine
  • Salmeterol
  • Pindolol
  • Formoterol
  • Salbutamol
  • Ergoloid mesylate
  • Isoprenaline
  • Arbutamine
  • Amiodarone
  • Carvedilol
  • Desipramine
  • Propafenone
  • Acebutolol
  • Nadolol
  • Levobunolol
  • Metipranolol
  • Aripiprazole
  • Arformoterol
  • Fenoterol
  • Pirbuterol
  • Bevantolol
  • Penbutolol
  • Ephedra sinica root
  • Ephedrine
  • Mephentermine
  • Procaterol
  • Clenbuterol
  • Bambuterol
  • Oxprenolol
  • Putrescine
  • Spermidine
  • Celiprolol
  • Nebivolol
  • Indacaterol
  • Bedoradrine
  • NCX 950
  • Asenapine
  • Droxidopa
  • Bufuralol
  • Protokylol
  • (S)-carazolol
  • Bopindolol
  • Bupranolol
  • Befunolol
  • Olodaterol
  • Vilanterol
  • Arotinolol
  • Doxofylline
  • Racepinephrine
  • Dihydroergocornine
  • DL-Methylephedrine
  • Etafedrine
  • Tulobuterol
  • Levosalbutamol
  • Dihydroergocristine
  • Asthma
AFAP1 actin filament associated protein 1
AKT3 AKT serine/threonine kinase 3
  • Activation of BAD and translocation to mitochondria
  • PIP3 activates AKT signaling
  • PIP3 activates AKT signaling
  • Downregulation of ERBB2:ERBB3 signaling
  • AKT phosphorylates targets in the cytosol
  • AKT phosphorylates targets in the cytosol
  • AKT phosphorylates targets in the nucleus
  • Negative regulation of the PI3K/AKT network
  • AKT-mediated inactivation of FOXO1A
  • CD28 dependent PI3K/Akt signaling
  • CTLA4 inhibitory signaling
  • G beta:gamma signalling through PI3Kgamma
  • VEGFR2 mediated vascular permeability
  • TP53 Regulates Metabolic Genes
  • Constitutive Signaling by AKT1 E17K in Cancer
  • Regulation of TP53 Degradation
  • Regulation of TP53 Activity through Acetylation
  • Regulation of TP53 Activity through Association with Co-factors
  • Cyclin E associated events during G1/S transition
  • Cyclin A:Cdk2-associated events at S phase entry
  • RAB GEFs exchange GTP for GDP on RABs
  • RUNX2 regulates genes involved in cell migration
  • Regulation of PTEN stability and activity
  • FLT3 Signaling
  • Regulation of localization of FOXO transcription factors
  • Estrogen-dependent nuclear events downstream of ESR-membrane signaling
APP amyloid beta precursor protein
  • Platelet degranulation
  • ECM proteoglycans
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • G alpha (q) signalling events
  • G alpha (i) signalling events
  • Lysosome Vesicle Biogenesis
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • The NLRP3 inflammasome
  • Advanced glycosylation endproduct receptor signaling
  • Advanced glycosylation endproduct receptor signaling
  • Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
  • Post-translational protein phosphorylation
  • TRAF6 mediated NF-kB activation
  • Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
  • Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
  • Purinergic signaling in leishmaniasis infection
  • Amyloid fiber formation
  • Deferoxamine
  • Aluminium
  • Zinc
  • L-methionine (R)-S-oxide
  • Resveratrol
  • Tromethamine
  • Phenserine
  • Tetrathiomolybdate
  • CAD106
  • Mito-4509
  • Edonerpic
  • Dimercaprol
  • Copper
  • Florbetaben (18F)
  • Florbetapir (18F)
  • Flutemetamol (18F)
  • Zinc acetate
  • Aluminium phosphate
  • Aluminum acetate
  • Zinc chloride
  • Zinc sulfate, unspecified form
  • Alzheimer's disease (AD)
ART3 ADP-ribosyltransferase 3 (inactive)
  • Post-translational modification: synthesis of GPI-anchored proteins
BDKRB2 bradykinin receptor B2
  • Peptide ligand-binding receptors
  • G alpha (q) signalling events
  • G alpha (i) signalling events
  • Anatibant
  • Icatibant
  • Labradimil
C1QBP complement C1q binding protein
  • Apoptotic factor-mediated response
  • Intrinsic Pathway of Fibrin Clot Formation
  • Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function
  • Hyaluronic acid
  • Copper
CD34 CD34 molecule
CDCP1 CUB domain containing protein 1
CHAT choline O-acetyltransferase
  • Synthesis of PC
  • Acetylcholine Neurotransmitter Release Cycle
  • Nicotine
  • Congenital myasthenic syndrome
CNP 2',3'-cyclic nucleotide 3' phosphodiesterase

Page 1 out of 7 pages